| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-802
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21005 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65B3-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65B5-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65B55-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
2011-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2018-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101814841-B1 |
| titleOfInvention |
Process for making dry and stable hemostatic compositions |
| abstract |
The present invention a) providing a first component comprising a dry formulation of a coagulation inducing agent; b) providing a second component comprising a dry preparation of a biocompatible polymer suitable for use in hemostasis; c) c1) filling the final container with the first component and the second component to obtain a dry mixture in the final container, or c2) providing the first component or the second component to the final container so as to obtain a combination of the first component and the second component in the final container, and the second component or the second component 1 < / RTI > Providing the first component and the second component in a combined form to a final container, d) a step of finishing the final container with a storageable pharmaceutical device containing the first component and the second component in a combined form as a dry and stable hemostatic composition, . |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020242231-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102093839-B1 |
| priorityDate |
2010-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |